Amyloid Solution

company

About

Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
₩14.50B
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
₩14.50B
Amyloid Solution has raised a total of ₩14.50B in funding over 2 rounds. Their latest funding was raised on Mar 26, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 26, 2019 Series A ₩14.50B 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Amyloid Solution is funded by 2 investors. Innopolis Partners and Saehan Startup Investment are the most recent investors.
Investor Name Lead Investor Funding Round
Innopolis Partners Series A
Saehan Startup Investment Series A